Kaat Bollaerts is a PhD-level biostatistician with over 15 years of experience in the field of epidemiology. After obtaining her PhD, she started working as a senior scientist at the Scientific Institute of Public Health, Belgium. Here she gained experience in diverse aspects of epidemiological research, ranging from setting up epidemiological studies to analyzing secondary databases. She holds leading positions in several European projects. She has plenty of experience in analyzing epidemiological data of all kinds and masters a wide variety of statistical techniques. Throughout her professional career, she is involved in consulting activities for private industry, governments and
(inter)national public health institutions and teaches at national and international vaccine courses. Kaat joined P95 in September 2013, and is currently Head of Data Science supporting a team of >15 statisticians and data scientists within P95. She is also the Principal Investigator of the COVIDRIVE
study estimating brand-specific COVID-19 vaccine effectiveness in Europe. Kaat co-authors the book “Vaccination Programmes: Epidemiology, Monitoring, Evaluation” (Hahné, Bollaerts, Farrington).